DA Davidson Reaffirms Neutral Rating for Procter & Gamble (NYSE:PG)

by · The Markets Daily

Procter & Gamble (NYSE:PGGet Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at DA Davidson in a research note issued on Tuesday, Benzinga reports. They currently have a $159.00 target price on the stock. DA Davidson’s price objective would suggest a potential downside of 8.61% from the company’s current price. DA Davidson also issued estimates for Procter & Gamble’s Q1 2025 earnings at $1.90 EPS, FY2025 earnings at $6.98 EPS and FY2026 earnings at $7.40 EPS.

PG has been the topic of several other reports. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research report on Monday, September 30th. Deutsche Bank Aktiengesellschaft raised their price target on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. TD Cowen assumed coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 target price for the company. Finally, Royal Bank of Canada increased their target price on shares of Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 31st. Nine research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $176.21.

Get Our Latest Stock Report on PG

Procter & Gamble Stock Performance

PG stock traded up $1.47 on Tuesday, reaching $173.98. The company’s stock had a trading volume of 1,838,016 shares, compared to its average volume of 6,658,719. The firm has a fifty day moving average of $171.57 and a two-hundred day moving average of $166.88. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The company has a market capitalization of $410.62 billion, a P/E ratio of 28.43, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. Procter & Gamble has a 52 week low of $142.50 and a 52 week high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same quarter in the previous year, the company earned $1.37 earnings per share. The firm’s quarterly revenue was down .1% compared to the same quarter last year. As a group, analysts predict that Procter & Gamble will post 6.97 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO R. Alexandra Keith sold 3,373 shares of Procter & Gamble stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the sale, the chief executive officer now owns 21,513 shares of the company’s stock, valued at approximately $3,657,210. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 383,194 shares of company stock worth $65,140,718 in the last 90 days. Corporate insiders own 0.17% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Steele Capital Management Inc. acquired a new stake in shares of Procter & Gamble during the first quarter worth $204,000. GAMMA Investing LLC boosted its holdings in Procter & Gamble by 67.2% during the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares during the last quarter. Consilio Wealth Advisors LLC increased its stake in shares of Procter & Gamble by 27.7% in the 1st quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock valued at $283,000 after acquiring an additional 379 shares during the last quarter. AMF Tjanstepension AB boosted its stake in Procter & Gamble by 416.1% during the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after acquiring an additional 1,466,115 shares during the last quarter. Finally, Talbot Financial LLC grew its holdings in Procter & Gamble by 1.5% during the first quarter. Talbot Financial LLC now owns 65,600 shares of the company’s stock valued at $10,644,000 after purchasing an additional 950 shares during the period. 65.77% of the stock is owned by institutional investors.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also